To provide an electrochromic element, which contains: a first electrode; a second electrode; and an electrolyte provided between the first electrode and the second electrode, wherein the first electrode contains a polymer product obtained through polymerization of an electrochromic composition where the electrochromic composition contains a radical polymerizable compound containing triarylamine.

To provide an electrochromic element, which contains: a first electrode; a second electrode; and an electrolyte provided between the first electrode and the second electrode, wherein the first electrode contains a polymer product obtained through polymerization of an electrochromic composition where the electrochromic composition contains a radical polymerizable compound containing triarylamine.

To provide an electrochromic element, which contains: a first electrode; a second electrode; and an electrolyte provided between the first electrode and the second electrode, wherein the first electrode contains a polymer product obtained through polymerization of an electrochromic composition where the electrochromic composition contains a radical polymerizable compound containing triarylamine.

A resist composition comprising a base polymer and a quencher in the form of an amine compound having an iodized aromatic ring bonded to the nitrogen atom via a divalent hydrocarbon group offers a high sensitivity and minimal LWR or improved CDU, independent of whether it is of positive or negative tone.

A compound of the formula, plus devices incorporating this compound, and a method of marking such devices: ##STR00001## wherein: A represents a phenyl group, a naphthyl group, a biphenyl group or two phenyl groups linked by a C.sub.1-C.sub.8 alkyl chain; B.sup.1 and B.sup.2 in each occurrence are independently selected side chains of the structure
—(Y.sup.1).sub.n-L-(Y.sup.2).sub.m—X wherein: Y.sup.1 and Y.sup.2 in each occurrence are independently selected from O, CO.sub.2— and CH.sub.2O, m and n in each occurrence are independently selected from 0 or 1; L in each occurrence is a C.sub.2-C.sub.14 straight chain alkyl group; and X in each occurrence is an independently selected cross linkable group; C is a side chain of the structure —(Z.sup.1).sub.p-M-(Z.sup.2).sub.q-E wherein: Z.sup.1 and Z.sup.2 are independently selected from O, CO.sub.2— and CH.sub.2O, p and q in each occurrence are independently selected from 0 or 1; M is a C.sub.1-C.sub.14 straight chain alkyl group; and E comprises a charge transport group; D is a side chain of the structure —(W.sup.1).sub.r—N—(W.sup.2).sub.s—F wherein: W.sup.1 and W.sup.2 are independently selected from O, CO.sub.2— and CH.sub.2O, r and s in each occurrence are independently selected from 0 or 1; N is a C.sub.1-C.sub.14 straight chain alkyl group; and F comprises a charge transport group or light emitter group; and wherein the charge transport group E does not contain a fluorene group other than those that form part of a spirobifluorenearylamine motif.

The present technology provides compounds selective for the Grp94 isoform, as well as compositions including such compounds, that are useful for treatment of multiple myeloma, melanoma, lung cancer, hepatocellular carcinoma, breast cancer, prostate cancer, and/or glaucoma. Methods using the compound are also provided.

The present technology provides compounds selective for the Grp94 isoform, as well as compositions including such compounds, that are useful for treatment of multiple myeloma, melanoma, lung cancer, hepatocellular carcinoma, breast cancer, prostate cancer, and/or glaucoma. Methods using the compound are also provided.

Disclosed is an application of an ionic iron (III) complex as a catalyst in preparation of a benzylamine compound, that is, an ionic iron (III) complex having a molecular formula of [(RNCHCHNR)CH][FeBr.sub.4] (R is tert-butyl) and containing 1,3-di-tert-butyl imidazolium cation is used as a catalyst, di-tert-butyl peroxide is used as an oxidizing agent, and a benzylamine compound is synthesized by oxidation reaction of a toluene/ethylbenzene compound with an aromatic amine. The present invention has a wide application range, and is applicable not only to a toluene compound containing a benzylic primary carbon-hydrogen bond but also to an ethylbenzene compound containing a benzyl secondary carbon-hydrogen bond. This is the first example of the preparation of a benzylamine compound by oxidation reaction of a toluene/ethylbenzene compound and an aromatic amine by an iron-based catalyst.

The present technology provides compounds selective for the Grp94 isoform, as well as compositions including such compounds, that are useful for treatment of multiple myeloma, melanoma, lung cancer, hepatocellular carcinoma, breast cancer, prostate cancer, and/or glaucoma. Methods using the compounds are also provided.

The disclosure provides processes for synthesizing compounds for use as CFTR modulators.

##STR00001##